KP Tissue, Inc.TSX: KPT

KP Tissue Releases Third Quarter 2026 Financial Results

· Issued by KP Tissue, Inc. via Newsfile

Summary by 6ix AI

KP Tissue Inc. (KPT), which holds a 12.0% interest in tissue maker Kruger Products Inc., had net income of $3.1 million for the third quarter ended September 30, 2026. Kruger Products' revenue was $589.7 million in the quarter, compared to $561.1 million in the third quarter of 2025, an increase of 5.1%.

Key details

  • Kruger Products' Adjusted EBITDA, a non-GAAP measure of earnings before interest, taxes, depreciation, amortization and certain other items, was $93.5 million, compared to $85.7 million a year earlier, an increase of 9.1%. Its net income was $27.7 million, compared to $14.6 million.
  • Kruger Products says the revenue increase was primarily due to higher sales volume in its Consumer segment along with favourable selling prices in its Consumer U.S. business.
  • KPT's net income included $3.3 million as its share of Kruger Products' net income, a dilution gain of $0.1 million and depreciation expense of $0.3 million related to adjustments to carrying amounts on acquisition.
  • KPT's board declared a quarterly dividend of $0.21 per share, to be paid on January 15, 2027 to shareholders of record at the close of business on December 31, 2026.
  • Kruger Products had total liquidity, meaning cash and availability under its revolving credit agreements, of $434.2 million as of September 30, 2026.

What’s still pending

  • Assuming a similar tariff environment, Kruger Products expects fourth quarter 2026 Adjusted EBITDA to be slightly below the third quarter of 2026 while remaining above the same quarter last year.
  • CEO Dino Bianco said a final location decision for Kruger Products' new tissue facility project will be deferred until there is greater certainty in the economic and trade environment, and the company anticipates the facility will be delayed and not commence operations in 2028.

6ix AI wrote this summary from the release below and checked it against the release.

Mississauga, Ontario--(Newsfile Corp. - November 11, 2026) - KP Tissue Inc. (TSX: KPT) (KPT) reports the Q3 2026 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and Bonterra®) and the Away-From-Home (AFH) market and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 12.0% interest in Kruger Products.

Kruger Products Q3 2026 Business and Financial Highlights

  • Revenue was $589.7 million in Q3 2026 compared to $561.1 million in Q3 2025, an increase of $28.6 million or 5.1%.
  • Adjusted EBITDA1 was $93.5 million in Q3 2026 compared to $85.7 million in Q3 2025, an increase of 9.1%.
  • Net income was $27.7 million in Q3 2026 compared to $14.6 million in Q3 2025, an increase of $13.1 million.
  • Declared a quarterly dividend of $0.21 per share to be paid on January 15, 2027.

"Our continued strong execution in the third quarter of 2026 has led us to deliver more than three consecutive years of profitable growth," stated Kruger Products' and KP Tissue's Chief Executive Officer, Dino Bianco. "Revenue and Adjusted EBITDA1 increased 5.1% and 9.1%, respectively, year-over-year despite an ongoing uncertain economic environment. We are particularly pleased with our robust sales growth in the U.S. In Canada, sales also grew in the third quarter, as we continued to invest in our brands. We remain focused on executing our share recovery plan which should deliver improving shares."

"Looking ahead, we expect to navigate escalating input costs and increased inflationary pressure. Among the cost mitigation measures under consideration are productivity initiatives and pricing adjustments. We continue to make progress on our new TAD facility project, however, a final location decision will be deferred until there is greater certainty in the economic and trade environment. Accordingly, we anticipate that the new TAD facility will be delayed and not commence operations in 2028," Mr. Bianco added.

Outlook for Q4 2026
Assuming a similar tariff environment, we expect Q4 2026 Adjusted EBITDA1 to be slightly below Q3 2026, while remaining above the same quarter last year.

Kruger Products Q3 2026 Financial Results
Revenue was $589.7 million in Q3 2026 compared to $561.1 million in Q3 2025, an increase of $28.6 million or 5.1%. The increase in revenue was primarily due to higher sales volume in the Consumer segment along with favourable selling prices in the Consumer U.S. business.

Cost of sales was $481.1 million in Q3 2026 compared to $460.0 million in Q3 2025, an increase of $21.1 million or 4.6%. The increase in cost of sales was primarily due to increased sales volumes, additional manufacturing overhead spend to invest in our sites as well as the unfavourable impact of foreign exchange fluctuations on U.S. dollar costs compared to the year ago quarter, partially offset by lower pulp costs. Freight rates increased due to higher diesel prices and carrier capacity constraints, while warehousing costs increased compared to Q3 2025 primarily as a result of handling costs related to higher sales volume. As a percentage of revenue, cost of sales was 81.6% in Q3 2026 compared to 82.0% in Q3 2025.

Selling, general and administrative (SG&A) expenses were $48.8 million in Q3 2026 compared to $47.9 million in Q3 2025, an increase of $0.9 million or 1.9%. The increase was primarily due to additional investment in IT, foreign exchange losses compared to gains in the prior year and higher compensation costs. This was partially offset by lower advertising and promotion spend compared to the year ago quarter. As a percentage of revenue, SG&A expenses were 8.3% in Q3 2026 compared to 8.5% in Q3 2025.

Adjusted EBITDA1 was $93.5 million in Q3 2026 compared to $85.7 million in Q3 2025, an increase of $7.8 million or 9.1%. The increase was primarily due to higher sales volumes and selling prices along with favourable pulp costs, partially offset by higher freight rates, manufacturing overhead spend and warehousing costs.

Net income was $27.7 million in Q3 2026 compared to $14.6 million in Q3 2025. This was primarily due to higher Adjusted EBITDA1, foreign exchange gain and lower interest expense. This was partially offset by higher income tax expense, higher depreciation and amortization, and higher income from non-controlling interest.

Kruger Products Q3 2026 Liquidity
Total liquidity, representing cash and availability under the revolving credit agreements, was $434.2 million as of September 30, 2026.

KPT Q3 2026 Financial Results
KPT had net income of $3.1 million in Q3 2026. Included in net income was $3.3 million representing KPT's share of Kruger Products' net income, a dilution gain of $0.1 million and depreciation expense of $0.3 million related to adjustments to carrying amounts on acquisition.

Dividends on Common Shares
The Board of Directors of KPT declared a quarterly dividend of $0.21 per share to be paid on January 15, 2027 to shareholders of record at the close of business on December 31, 2026.

Additional Information
For additional information please refer to Management's Discussion and Analysis (MD&A) of KPT and Kruger Products for the third quarter ended September 30, 2026 available on SEDAR+ at www.sedarplus.ca or our website at www.kptissueinc.com.

Third Quarter Results Conference Call Information
KPT will hold its third quarter conference call on Wednesday, November 11, 2026 at 8:30 a.m. Eastern Time.
Via telephone: 1-888-699-1199 or 416-945-7677
Via internet: www.kptissueinc.com

Presentation material referenced during the conference call will be available at www.kptissueinc.com.

A rebroadcast of the conference call will be available until midnight, November 18, 2026, by dialing 1-888-660-6345 or 289-819-1450 and entering passcode 13547.

The replay of the webcast will remain available on the website until midnight, November 18, 2026.

About KP Tissue Inc.
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12.0% interest in Kruger Products. For more information visit www.kptissueinc.com.

About Kruger Products Inc.
Kruger Products is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. Kruger Products serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and Bonterra®. In the U.S., Kruger Products manufactures the White Cloud® brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. Kruger Products has approximately 3,000 employees and operates ten FSC® COC-certified (FSC® C-104904) production facilities in North America. For more information visit www.krugerproducts.ca.

Non-GAAP Financial Measures
This press release uses certain non-GAAP financial measures which Kruger Products believes provide useful information to management of Kruger Products and the readers of the financial information in measuring the financial performance and financial condition of Kruger Products. These measures do not have a standardized meaning prescribed by GAAP and therefore may not be comparable to similarly titled measures presented by other companies. An example of such a measure is Adjusted EBITDA. Adjusted EBITDA is not a measurement of operating performance computed in accordance with GAAP and should not be considered as a substitute for operating income, net income or cash flows from operating activities computed in accordance with GAAP. "Adjusted EBITDA" is calculated by Kruger Products as net income (loss) before (i) interest expense and other finance costs, (ii) income taxes, (iii) depreciation, (iv) amortization, (v) loss on sale of non-financial assets, (vi) loss (gain) on disposal of property, plant and equipment, (vii) foreign exchange loss (gain), (viii) costs related to restructuring activities and (ix) other (income) expense. A reconciliation of Adjusted EBITDA to the relevant reported results can be found in the Segment and Geographic Results table of this press release.

Forward-Looking Statements
Certain statements in this press release about KPT's and Kruger Products' current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward-looking statements. Forward-looking statements in this press release include, but are not limited to, items such as plans to build a new TAD tissue plant and its expected annual production capacity, expected date for starting production, the expected financing structure of the project and certain anticipated benefits of the project. The words "may", "will", "would", "should", "could", "expects", "plans", "intends", "trends", "indications", "anticipates", "believes", "estimates", "predicts", "likely" or "potential" or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements. The forward-looking statements are based on certain key expectations and assumptions made by KPT or Kruger Products, in respect of the plans to build a new TAD tissue plant, and obtaining financing on acceptable terms for the project. Although KPT and Kruger Products believe that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking statements since no assurance can be given that such expectations and assumptions will prove to be correct.

The outlook provided in respect of Adjusted EBITDA1 for Q4 2026 is forward-looking information and is based on the assumptions and subject to the risk and uncertainties referred to below. The purpose of the outlook is to provide the reader with an indication of management's expectations, at the date of this press release, regarding Kruger Products' future financial performance. Readers are cautioned that this information may not be appropriate for other purposes.

Many factors could cause Kruger Products' actual results, level of activity, performance or achievements or future events or developments (which could in turn affect the economic benefits derived from KPT's economic interest in Kruger Products) to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the following factors, which are discussed in greater detail in the "Risk Factors - Risks Related to Kruger Products' Business" section of the KPT Annual Information Form dated February 18, 2026 available on SEDAR+ at www.sedarplus.ca (the Annual Information Form): Kruger Inc.'s influence over Kruger Products; Kruger Products' reliance on Kruger Inc.; consequences of an event of insolvency relating to Kruger Inc.; risks associated with the ownership of the TAD Sherbrooke Project; risks associated with the operation of the TAD Sherbrooke Project; operational risks; significant increases in input costs; reduction in supply of fibre; increased pricing pressure and intense competition; Kruger Products' inability to innovate effectively; adverse economic conditions; dependence on key retail trade customers; damage to the reputation of Kruger Products or Kruger Products' brands; Kruger Products' sales being less than anticipated; Kruger Products' failure to implement its business and operating strategies; Kruger Products' obligation to make regular capital expenditures; Kruger Products entering into unsuccessful acquisitions; Kruger Products' dependence on key personnel; Kruger Products' inability to retain its existing customers or obtain new customers; Kruger Products' loss of key suppliers; Kruger Products' failure to adequately protect its intellectual property rights; Kruger Products' reliance on third party intellectual property licenses; adverse litigation and other claims affecting Kruger Products; material expenditures due to comprehensive environmental regulation affecting Kruger Products' cash flow; Kruger Products' pension obligations are significant and can be materially higher than predicted if Kruger Products Management's underlying assumptions are incorrect; labour disputes adversely affecting Kruger Products' cost structure and Kruger Products' ability to run its plants; exchange rate and U.S. competitors; Kruger Products' inability to service all of its indebtedness; exposure to potential consumer product liability; covenant compliance; interest rate and refinancing risk; information technology; cyber-security; insurance; internal controls; trade related and tax.

Readers should not place undue reliance on forward-looking statements made herein. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information contained herein is made as of the date of press release and KPT undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent or otherwise, unless required by applicable securities laws.

INFORMATION:
Francois Paroyan
General Counsel and Corporate Secretary
KP Tissue Inc.
905-812-6936
francois.paroyan@krugerproducts.ca

INVESTORS:
Doris Grbic
Senior Director, Investor Relations
KP Tissue Inc.
437-882-2596
IR@krugerproducts.ca

¹ Adjusted EBITDA is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures section of this press release for more information on these measures.

Kruger Products Inc.
Unaudited Condensed Consolidated Statements of Financial Position
(thousands of Canadian dollars)
September 30, 2026December 31, 2025
$$
Assets
Current assets
Cash and cash equivalents176,407196,094
Restricted cash30,15046,070
Trade and other receivables165,728143,313
Receivables from related parties14379
Inventories332,643284,183
Income tax recoverable7,2712,963
Prepaid expenses12,4885,381
724,830678,083
Non-current assets
Property, plant and equipment1,421,1741,430,206
Right-of-use assets182,958152,243
Other long-term assets30,614498
Pensions126,15891,118
Goodwill152,021152,021
Intangible assets38,00740,362
Deferred income tax asset51,45664,671
Total assets2,727,2182,609,202
Liabilities
Current liabilities
Trade and other payables367,033350,831
Payables to related parties12,13813,441
Dividends payable15,34514,853
Current portion of long-term debt89,92398,649
Current portion of lease liabilities43,78743,576
Current portion of long-term payable to related party5,8005,800
Current portion of provisions6,8847,283
540,910534,433
Non-current liabilities
Long-term debt1,055,2421,074,646
Long-term lease liabilities173,471139,694
Long-term payable to related party23,57928,064
Long-term provisions12,26412,602
Pensions18,16117,745
Post-retirement benefits46,89348,333
Deferred income tax liability72,04347,140
Total liabilities1,942,5631,902,657
Equity
Share capital346,535334,479
Contributed surplus395,382395,382
Deficit(96,543)(151,965)
Accumulated other comprehensive income95,68289,343
Equity attributable to Kruger Products741,056667,239
Non-controlling interest43,59939,306
Total equity784,655706,545
Total liabilities and equity2,727,2182,609,202
Kruger Products Inc.
Unaudited Condensed Consolidated Statements of Income
(thousands of Canadian dollars)
3-month3-month9-month9-month
period endedperiod endedperiod endedperiod ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
$$$$
Revenue589,655561,1451,685,1931,643,335
Expenses
Cost of sales481,019459,9881,358,0641,373,175
Selling, general and administrative expenses48,82347,906151,113146,277
Restructuring costs-293733,731
Operating income59,81353,222175,643120,152
Interest expense and other finance costs18,70721,56958,36463,826
Other expense (income)(708)6,83610,096(13,448)
Income before income taxes41,81424,817107,18369,774
Current tax expense1,2072422,6042,050
Deferred tax expense11,1229,19130,6499,274
Income tax expense12,3299,43333,25311,324
Net income including non-controlling interest29,48515,38473,93058,450
Net income attributable to non-controlling interest1,7778384,2936,362
Net income attributable to Kruger Products27,70814,54669,63752,088
Kruger Products Inc.
Unaudited Condensed Consolidated Statements of Cash Flows
(thousands of Canadian dollars)
3-month3-month9-month9-month
period endedperiod endedperiod endedperiod ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
$$$$
Cash flows from (used in) operating activities
Net income including non-controlling interest29,48515,38473,93058,450
Items not affecting cash
Depreciation31,44830,25989,637103,875
Amortization2,2332,1905,3666,170
Loss (gain) on sale of property, plant and equipment1-1(5)
Loss (gain) on disposal of leased assets(3)-(3)23
Fair value gain on derivative asset(174)-(174)-
Foreign exchange loss (gain)(534)6,83610,270(13,448)
Interest expense and other finance costs18,70721,56958,36463,826
Pension and post-retirement benefits2,7302,8448,1308,417
Provisions2,1081,9305,2945,859
Income tax expense12,3299,43333,25311,324
Total items not affecting cash68,84575,061210,138186,041
Net change in non-cash working capital(11,983)25,096(71,042)(29,471)
Contributions to pension and post-retirement benefit plans712(869)(1,308)(2,884)
Provisions paid(93)(655)(7,230)(4,679)
Income tax payments, net(497)(681)(1,743)(2,492)
Net cash from operating activities86,469113,336202,745204,965
Cash flows from (used in) investing activities
Purchases of property, plant and equipment(19,411)(13,451)(48,208)(23,313)
Purchases of property, plant and equipment related to the
Sherbrooke Expansion Project(664)(1,796)(2,344)(19,173)
Government assistance received-(31)3,4973,119
Investment in derivative asset(1,027)-(28,875)-
Purchase of software(2,500)(989)(3,017)(2,083)
Net cash used in investing activities(23,602)(16,267)(78,947)(41,450)
Cash flows from (used in) financing activities
Proceeds from long-term debt-(22,017)-9,171
Repayment of long-term debt(20,457)(16,613)(54,210)(49,118)
Payment of deferred financing fees(230)(30)(1,057)(23)
Payment of lease liabilities(11,466)(8,738)(31,051)(25,475)
Change in restricted cash(1,716)31,68015,9203,730
Interest paid on long-term debt(6,784)(9,975)(35,628)(41,396)
Payment to related party--(5,800)(5,800)
Dividends paid(15,289)(14,596)(45,065)(43,352)
Proceeds from issuing partnership units4,0166,46111,99719,147
Net cash used in financing activities(51,926)(33,828)(144,894)(133,116)
Effect of exchange rate changes on cash and cash
equivalents held in foreign currency2435831,409(728)
Increase (decrease) in cash and cash equivalents
during the period11,18463,824(19,687)29,671
Cash and cash equivalents - Beginning of period165,22385,307196,094119,460
Cash and cash equivalents - End of period176,407149,131176,407149,131
Kruger Products Inc.
Unaudited Segment and Geographic Results
(thousands of Canadian dollars)
3-month3-month9-month9-month
period endedperiod endedperiod endedperiod ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
$$$$
Segment Information
Segment Revenue
Consumer492,774468,3131,412,0631,382,725
AFH96,88192,832273,130260,610
Revenue from external customers589,655561,1451,685,1931,643,335
Other segment items
Consumer404,804390,0691,154,8501,159,245
AFH87,93282,453249,370238,479
Corporate and other costs3,4262,9229,95311,665
Total other segment items496,162475,4441,414,1731,409,389
Adjusted EBITDA
Consumer87,97078,244257,213223,480
AFH8,94910,37923,76022,131
Corporate and other costs(3,426)(2,922)(9,953)(11,665)
Total Adjusted EBITDA93,49385,701271,020233,946
Reconciliation to net income (loss)
Depreciation and amortization33,67932,45095,003110,045
Interest expense and other finance costs18,70721,56958,36463,826
Loss on disposal of property, plant and equipment1-118
Restructuring costs, net-293733,731
Other income(174)-(174)-
Foreign exchange loss (gain)(534)6,83610,270(13,448)
Income before income taxes41,81424,817107,18369,774
Income tax expense12,3299,43333,25311,324
Net income including non-controlling interest29,48515,38473,93058,450
Geographic Revenue
Canada311,069301,360891,933889,217
US278,586259,785793,260754,118
Total revenue589,655561,1451,685,1931,643,335
KP Tissue Inc.
Unaudited Condensed Statements of Financial Position
(thousands of Canadian dollars)
September 30, 2026December 31, 2025
$$
Assets
Current assets
Dividends receivable2,1071,803
2,1071,803
Non-current assets
Investment in associate76,29369,799
Total assets78,40071,602
Liabilities
Current liabilities
Dividends payable2,1071,803
Total liabilities2,1071,803
Equity
Common shares23,19423,001
Contributed surplus144,819144,819
Deficit(109,511)(114,985)
Accumulated other comprehensive income17,79116,964
Total equity76,29369,799
Total liabilities and equity78,40071,602
KP Tissue Inc.
Unaudited Condensed Statements of Income
(thousands of Canadian dollars, except share and per share amounts)
3-month3-month9-month9-month
period endedperiod endedperiod endedperiod ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
$$$$
Share of income3,3101,7008,3596,372
Depreciation of fair value increments(269)(264)(808)(827)
Equity income3,0411,4367,5515,545
Dilution gain59114171323
Net income3,1001,5507,7225,868
Basic and diluted earning per share0.310.150.770.59
Weighted average number of shares outstanding10,031,67510,007,05710,026,64310,000,087
KP Tissue Inc.
Unaudited Statements of Cash Flows
(thousands of Canadian dollars)
3-month3-month9-month9-month
period endedperiod endedperiod endedperiod ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
$$$$
Cash flows from (used in) operating activities
Net income3,1001,5507,7225,868
Items not affecting cash
Equity income(3,041)(1,436)(7,551)(5,545)
Dilution gain(59)(114)(171)(323)
Total items not affecting cash(3,100)(1,550)(7,722)(5,868)
Net cash from operating activities----
Cash flows from (used in) investing activities
Dividends received, net2,0461,7395,5225,229
Net cash from investing activities2,0461,7395,5225,229
Cash flows from (used in) financing activities
Dividends paid, net(2,046)(1,739)(5,522)(5,229)
Net cash used in financing activities(2,046)(1,739)(5,522)(5,229)
Increase in cash and cash equivalents during the period----
Cash and cash equivalents - Beginning of period----
Cash and cash equivalents - End of period----

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/322858

View original source (Newsfile)KP Tissue, Inc. on 6ix

In the deck

Story so far

Earlier from KP Tissue

Later from KP Tissue

All KP Tissue news releases